AI echocardiography using multimodal right ventricular assessment predicted mortality in pulmonary hypertension. Learn more.

Orphai Therapeutics Inc. ("Orphai"), a clinical-stage biopharmaceutical company dedicated to advancing novel therapeutics for patients with diseases of significant unmet need, today announced that ...

Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...

DURHAM, NC and LONDON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, today announced the expansion of its Xenon MRI ...

New UC San Diego Health research shows a simple blood test could help doctors catch serious heart problems early.

Panelists discuss how pulmonary arterial hypertension diagnosis requires comprehensive evaluation including right heart catheterization to confirm hemodynamic criteria, with normal mean PA pressure ...

Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic ...

Pulmonary hypertension in kidney transplant recipients is associated with lower graft and patient survival. Pre-existing pulmonary hypertension in kidney transplant recipients (PHTN) is associated ...

SaveHealth reports on 10 hypertension medications, their classifications, effectiveness, side effects, and safety in managing high blood pressure.